Cited by 26Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and TherapyLysosomal Storage Disorders Research

What lysosomes actually tell us about Parkinson’s disease?

Bourdenx, Mathieu, Dehay, Benjamin·2016·Ageing Research Reviews

Abstract

Parkinson's disease is a common neurodegenerative disorder of unknown origin mainly characterized by the loss of neuromelanin-containing dopaminergic neurons in the substantia nigra pars compacta and the presence of intraneuronal proteinaceous inclusions called Lewy bodies. Lysosomes are dynamic organelles that degrade, in a controlled manner, cellular components delivered via the secretory, endocytic, autophagic and phagocytic membrane-trafficking pathways. Increasing amounts of evidence suggest a central role of lysosomal impairment in PD aetiology. This review provides an update on how genetic evidence support this connection and highlights how the neuropathologic and mechanistic evidence might relate to the disease process in sporadic forms of Parkinson's disease. Finally, we discuss the influence of ageing on lysosomal impairment and PD aetiology and therapeutic strategies targeting lysosomal function.

Integrity signals

Registry

Crossref · 10.1016/j.arr.2016.02.008

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Similar CTSD changes in fibroblasts carrying the ATP13A2 mutation in Parkinson disease were reversed by normalizing lysosomal pH with acidic nanoparticles.

    “Similar CTSD changes seen in fibroblasts carrying the ATP13A2 mutation in Parkinson disease (Bourdenx and Dehay, 2016) were reversed by normalizing lysosomal pH with acidic nanoparticles”

    From Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99) (2019) · cites this paper as Bourdenx and Dehay, 2016

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bourdenx, M., & Dehay, B.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Dehay, Benjamin
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2016-12
Volume
32
Pages
140-149
ISSN
1568-1637 (ISSN-L)
OpenAlex
W2293020656
Cited by
26
References
7
Citations by year
2026: 1 · 2025: 4 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 2
FWCI
0.69
Type
journal article
Language
en
Open access
closed
Locations
  • Ageing Research Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
Marie Curie Reintegration (FP7- PEOPLE-2009-ERG256303)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
Keywords
Parkinson's disease, lysosomes, lysosomal dysfunction, Lewy bodies, dopaminergic neurons, substantia nigra, autophagy, endocytosis, phagocytosis, membrane trafficking, genetic risk factors, aging, neurodegeneration
MeSH terms
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Aging, Autophagy, Humans, Lysosomes, Melanins, Nerve Degeneration, Parkinson Disease, Substantia Nigra, Lewy Bodies, Vesicular Transport Proteins, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review